Arbutus Biopharma ABUS
NASDAQ ABUS
$4.18 -0.15 (-3.46%)
At close: Oct 21, 2026 · 4:00 PM EDT

Arbutus Biopharma (ABUS) EV to EBITDA (2026)

Updated

Arbutus Biopharma's (ABUS) EV to EBITDA was 5.49 for Q2 2026, down 5.3% from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) EV to EBITDA (2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Arbutus Biopharma's EV to EBITDA came in at 3.69.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Arbutus Biopharma 826.41 Mn 453.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.49
Mar 31, 2026 5.80
API Access

Arbutus Biopharma EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ABUS&period=max&api_key=YOUR_API_KEY